| |
| | JN 2004; Vol.17 n.3: 441-445 (Site not responding. Last check: 2007-10-12) |
 | | Alkaptonuria (ochronosis) is a rare autosomal recessive metabolic disorder due to homogentisate 1,2-dioxy-genase deficiency (also known as homogentisic acid oxidase (HGO)), an enzyme in tyrosine catabolism (1). |
 | | The treatment of alkaptonuria is symptomatic; however, nitisinone has been proposed as a potential therapy because it inhibits the enzyme that produces HGA (5, 6, 8, 9). |
 | | Alkaptonuria has been found at low prevalence (approximately 1 in 250,000) in all ethnic populations other than the Dominicians and Slovakians where much higher incidences (1 in 19,000 newborns) have been reported, but chronic renal failure in alka-ptonuria is extremely rare (4, 6, 10, 17, 18). |
| www.sin-italy.org /jnonline/Vol17n3/441.html (2160 words) |
|